Design and Synthesis of Handles for Solid-Phase Peptide Synthesis And

Total Page:16

File Type:pdf, Size:1020Kb

Design and Synthesis of Handles for Solid-Phase Peptide Synthesis And Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2003 Design and synthesis of handles for solid-phase peptide synthesis and convergent peptide synthesis Jose Giraldes Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Chemistry Commons Recommended Citation Giraldes, Jose, "Design and synthesis of handles for solid-phase peptide synthesis and convergent peptide synthesis" (2003). LSU Doctoral Dissertations. 1146. https://digitalcommons.lsu.edu/gradschool_dissertations/1146 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. DESIGN AND SYNTHESIS OF HANDLES FOR SOLID-PHASE PEPTIDE SYNTHESIS AND CONVERGENT PEPTIDE SYNTHESIS A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Chemistry by José Giraldés B.S., University of Puerto Rico, 1997 May, 2003 To my family ii ACKNOWLEDGMENTS I would like to thank my major professor Dr. Mark McLaughlin for his invaluable guidance and support during my stay at LSU. I am very grateful for the freedom and encouragement he gave me to develop my own ideas. A major amount of thanks must be given to Dr. Frank Zhou for the magic angle spinning NMR, to Martha Juban for help with peptide synthesis and purification, to Dr. Frank Fronczek for crystal structure determinations and to Dr. Tracy McCarley and Ms. Renee Sims for mass specs. I also greatly appreciate the scientific discussions with many former current students and post-docs in our laboratory work: Dr. Umut Oguz, Mr. Caleb Clark, Dr. Tanaji Talele, Dr. Mohanraj Kumar, Dr. Ted Gauthier and Dr. Lars Hammarström.. I would also like to thank my friends for their kindness and support: Mr. Leonardo Baez, Dr. Alfonso Davila, Dr. Rachel Bolzan and Dr. Robert Koza. Finally I would like to thank all of my committee members for supervising my work with continuous encouragement: Dr. William Crowe, Dr. Robert Strongin, Dr. Steven Watkins and Dr. Ding Shih. iii TABLE OF CONTENTS DEDICATION ...................................................................................................ii ACKNOWLEDGEMENTS .............................................................................iii LIST OF TABLES.............................................................................................vi LIST OF FIGURES ...........................................................................................vii LIST OF ABBREVIATIONS ...........................................................................xi ABSTRACT........................................................................................................xv CHAPTER 1. ACID LABILE LINKERS FOR SOLID PHASE SYNTHESIS OF PEPTIDES....................................................1 1.1 Introduction........................................................................................1 1.2 Literature Review...............................................................................7 CHAPTER 2. DESIGN AND SYNTHESIS OF NOVEL FERROCENE LINKER………………………………………………………36 2.1 Introduction........................................................................................36 2.2 Design of the Ferrocene Linker..........................................................38 2.3 Results and Discussion ......................................................................39 2.4 Experimental......................................................................................45 2.4.1 4-Ferrocenyl-4-oxobutanoic Acid.............................................45 2.4.2 2-Propenyl-4-ferrocenyl-4-oxobutanoate..................................46 2.4.3 Ferrocenyl-1-hydrazide butanoic Acid......................................47 2.4.4 2-Methyl 4-ferrocenyl-4-oxohexanoate ....................................47 2.4.5 Ferrocenyl-1 hydrazide hexanoic Acid .....................................48 2.4.6 Ferrocenyl-1,1'-acid Fluoride....................................................48 2.4.7 Methyl ferrocenecarboxylate.....................................................49 2.4.8 Methyl-1'-formyl-1-ferrocene carboxylateferrocene.................50 2.4.9 Hept-6-enylamine......................................................................50 2.4.10 Ferrocenyl-imine-glycine(ethylester), methoxycarbonyl ........51 2.4.11 Ferrocene-methylglycine-ethyl ester, methoxycarbonyl .........52 2.4.12 Ferrocene-1-carboxylic acid-1`carboxaldehyde......................52 2.4.13 Ferrocene carboxaldehyde Resin ............................................53 2.4.14 Ferrocenyl heptenoic amine Resin..........................................57 2.4.15 Agni[(KLAKKLA)2] (2.24)using ferrocenyl heptenoic amine Resin............................................................................57 2.4.16 Ferrocene carboxaldehyde-polystyrene Resin.........................58 2.4.17 Allyl-amino ferrocenyl polystyrene Resin ..............................59 2.4.18 Allyl-amino fmoc-phenylalanine ferrocenyl polystyrene Resin .......................................................................................59 iv 2.4.19 Cleavage of (1-allylcarbamoyl-2-phenyl-ethyl)-carbamic acid 9H-fluoren-9-ylmethyl ester from allyl-amino ferrocenyl polystyrene Resin...................................................60 CHAPTER 3. CONVERGENT PEPTIDE SYNTHESIS ............................61 3.1 Introduction........................................................................................61 3.2 Secondary Structure ...........................................................................64 3.3 Solid-Phase Peptide Synthesis Methods ............................................66 3.4 Convergent Peptide Synthesis............................................................70 3.4.1 Convergent Solid-Phase Peptide Synthesis(CSPPS) of Protected Peptide Segments......................................................71 3.4.2 Chemoselective ligation of Unprotected Peptide Fragments..................................................................................74 3.5 Results and Discussion ......................................................................77 3.6 Experimental......................................................................................81 3.6.1 Peptide Synthesis ......................................................................81 3.6.2 Cyh-7.........................................................................................84 3.6.3 Cyh-7 MIC Assays....................................................................85 3.6.4 16-Hydroxypalmitoleic Acid ....................................................86 3.6.5 Peptide Synthesis Agni[ Glu(O-All)(KLAKKLA)2heptenoic Acid] .....................87 3.7 Ring Closing Methatesis Peptide Ligation............................................87 3.7.1 Attempted Peptide Ligation ......................................................88 3.7.2 Attempted Peptide Ligation ......................................................88 CHAPTER 4 CONCLUSION AND FUTURE STUDIES ..........................89 4.1 Discussion.............................................................................................89 REFERENCES.............................................................................................. …90 VITA....................................................................................................................96 v LIST OF TABLES Table 1.1 Common protecting groups used in SPPS where side chains are cleaved mild to moderate acidic conditions........................................5 Table 3.1 Common coupling reagents used in SPPS .........................................69 Table 3.2 Examples of large synthetic peptides and small proteins synthesized by SPPS...........................................................................70 Table 3.3 Methods for ligating unprotected peptides..........................................75 Table 3.4 Minimum inhibitory concentration of Cyh-7 ......................................86 vi LIST OF FIGURES Figure 1.1 Schematic representation of a peptide synthesis...............................1 Figure 1.2 Purification of compounds bound to the solid support from those in solution by simple filtration............................2 Figure 1.3 General scheme for solid-phase peptide synthesis page...................4 Figure 1.4 Cleavage of peptide from the linker PAL.........................................7 Figure 1.5 Cleavage of peptide from BAL(Backbone amide linker) .................8 Figure 1.6 Cleavage of peptide from trityl resin ................................................9 Figure 1.7 Cleavage of peptide from the Rink linker.........................................10 Figure 1.8 Methoxy substituted benzyl amine linkers ......................................11 Figure 1.9 Peptide cleavage from BDMTA resin .............................................11 Figure 1.10 Cleavage of peptide from BHA resin ..............................................12 Figure 1.11 Cleavage of peptide from MBHA resin...........................................13 Figure 1.12 Peptide cleavage using Alkoxybenzylamine linker
Recommended publications
  • (12) United States Patent (10) Patent No.: US 7,256.253 B2 Bridon Et Al
    US00725.6253B2 (12) United States Patent (10) Patent No.: US 7,256.253 B2 Bridon et al. (45) Date of Patent: Aug. 14, 2007 (54) PROTECTION OF ENDOGENOUS 6,500,918 B2 12/2002 Ezrin et al. THERAPEUTIC PEPTIDES FROM 6,514,500 B1 2/2003 Bridon et al. PEPTIDASE ACTIVITY THROUGH 6,593,295 B2 7/2003 Bridon et al. CONUGATION TO BLOOD COMPONENTS 6,602,981 B2 8/2003 Ezrin et al. 6,610,825 B2 8, 2003 Ezrin et al. (75)75 Inventors: Dominique P. Bridon, San Francisco, 6,706,892 B1 3/2004 Ezrin et al. CA (US); Alan M. Ezrin, Moraga, CA (US); Peter G. Milner, Los Altos, CA 6,849,714 B1 2/2005 Bridon et al. (US); Darren L. Holmes, Anaheim, CA 2002fOO18751 A1 2/2002 Bridon et al. (US); Karen Thibaudeau, Rosemere 2003, OO73630 A1 4/2003 Bridon et al. (CA) 2003/O105867 A1 6/2003 Colrain et al. 2003. O108568 A1 6/2003 Bridon et al. (73) Assignee: Conjuchem Biotechnologies Inc., 2003/0170250 A1 9, 2003 EZrin et al. Montreal (CA) 2004/O127398 A1 7, 2004 Bridon et al. (*) Notice: Subject to any disclaimer, the term of this 2004/O138100 A1 7/2004 Bridon et al. patent is extended or adjusted under 35 2004/O156859 A1 8, 2004 Ezrin et al. U.S.C. 154(b) by 0 days. 2004/0248782 A1 12/2004 Bridon et al. 2004/0266673 Al 12/2004 Bakis et al. (21) Appl. No.: 11/066,697 2005, 0037974 A1 2/2005 Krantz et al. 2005, OO65075 A1 3, 2005 Erickson et al.
    [Show full text]
  • Peptide Synthesis: Chemical Or Enzymatic
    Electronic Journal of Biotechnology ISSN: 0717-3458 Vol.10 No.2, Issue of April 15, 2007 © 2007 by Pontificia Universidad Católica de Valparaíso -- Chile Received June 6, 2006 / Accepted November 28, 2006 DOI: 10.2225/vol10-issue2-fulltext-13 REVIEW ARTICLE Peptide synthesis: chemical or enzymatic Fanny Guzmán Instituto de Biología Pontificia Universidad Católica de Valparaíso Avenida Brasil 2950 Valparaíso, Chile Fax: 56 32 212746 E-mail: [email protected] Sonia Barberis Facultad de Química, Bioquímica y Farmacia Universidad Nacional de San Luis Ejército de los Andes 950 (5700) San Luis, Argentina E-mail: [email protected] Andrés Illanes* Escuela de Ingeniería Bioquímica Pontificia Universidad Católica de Valparaíso Avenida Brasil 2147 Fax: 56 32 2273803 E-mail: [email protected] Financial support: This work was done within the framework of Project CYTED IV.22 Industrial Application of Proteolytic Enzymes from Higher Plants. Keywords: enzymatic synthesis, peptides, proteases, solid-phase synthesis. Abbreviations: CD: circular dichroism CLEC: cross linked enzyme crystals DDC: double dimer constructs ESI: electrospray ionization HOBT: hydroxybenzotriazole HPLC: high performance liquid hromatography KCS: kinetically controlled synthesis MALDI: matrix-assisted laser desorption ionization MAP: multiple antigen peptide system MS: mass spectrometry NMR: nuclear magnetic resonance SPS: solution phase synthesis SPPS: solid-phase peptide synthesis t-Boc: tert-butoxycarbonyl TCS: thermodynamically controlled synthesis TFA: trifluoroacetic acid Peptides are molecules of paramount importance in the medium, biocatalyst and substrate engineering, and fields of health care and nutrition. Several technologies recent advances and challenges in the field are analyzed. for their production are now available, among which Even though chemical synthesis is the most mature chemical and enzymatic synthesis are especially technology for peptide synthesis, lack of specificity and relevant.
    [Show full text]
  • Monoclonal Antibody to Parathyroid Hormone / PTH (1-38) - Purified
    OriGene Technologies, Inc. OriGene Technologies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] AM02147PU-N Monoclonal Antibody to Parathyroid hormone / PTH (1-38) - Purified Alternate names: Parathormone, Parathyrin Quantity: 0.1 mg Background: Parathyroid hormone (PTH), or Parathormone, is secreted by the parathyroid glands as a polypeptide containing 84 amino acids. It acts to increase the concentration of calcium in the blood, whereas calcitonin (a hormone produced by the parafollicular cells of the thyroid gland) acts to decrease calcium concentration. Uniprot ID: P01270 NCBI: NP_000306.1 GeneID: 5741 Host / Isotype: Mouse / IgG1 Recommended Isotype SM10P (for use in human samples), AM03095PU-N Controls: Clone: A1/70 Immunogen: Synthetic Human PTH (aa 1-38) poly-Lysine conjugated. AA Sequence: SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALG Format: State: Lyophilized purified IgG fraction from Cell Culture Supernatant Purification: Protein G Chromatography Buffer System: PBS, pH 7.4 Reconstitution: Restore in aqua bidest to 1 mg/ml Applications: RIA: 20 ng/ml. ELISA: 1 µg/ml (Ref.1). ILMA: 20 µg/ml (Ref.3). Immunohistochemistry on Cryosections and Paraffin Sections: 2 µg/ml. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. Specificity: This antibody detects PTH peptide (aa 15-25; 1-34; 1-38; 1-84; 7-84). There were no cross reactivities obtained with synthetic Human PTH (aa 1-3; 1-10; 4-16; 28-48; 39-84; 44-68; 53-84) nor with PTHrP (aa 1-86), Calcitonin, Gastrin, Beta-2 Microglobulin, Thymulin, Thyroglobulin, Streptavidin, or Glutathione S-transferase.
    [Show full text]
  • Activity of the Pineal Gland, Thymus and Hypophysial- Adrenal System in Oncological Patients I.F
    138 Experimental Oncology 25, 138-142, 2003 (June) ACTIVITY OF THE PINEAL GLAND, THYMUS AND HYPOPHYSIAL- ADRENAL SYSTEM IN ONCOLOGICAL PATIENTS I.F. Labunets*, Yu.A. Grinevich Institute of Oncology, Academy of Medical Sciences of Ukraine, Kyiv 03022, Ukraine ÀÊÒÈÂÍÎÑÒÜ ÝÏÈÔÈÇÀ, ÒÈÌÓÑÀ È ÃÈÏÎÔÈÇÀÐÍÎ- ÍÀÄÏÎ×Å×ÍÈÊÎÂÎÉ ÑÈÑÒÅÌÛ Ó ÁÎËÜÍÛÕ ÎÍÊÎËÎÃÈ×ÅÑÊÎÃÎ ÏÐÎÔÈËß È.Ô. Ëàáóíåö*, Þ.À. Ãðèíåâè÷ Èíñòèòóò îíêîëîãèè ÀÌÍ Óêðàèíû, Êèåâ, Óêðàèíà Melatonin, thymic serum factor (FTS), alpha-melanocytestimulating hormone (alpha-MSH) and cortisol levels in blood serum and urine of healthy subjects and patients with skin melanoma and malignant thymoma of different age groups have been studied. It has been found that in healthy 20–29 year old men the highest melatonin level was observed in winter, those of FTS, cortisol and alpha-MSH — in summer-autumn, autumn-winter and summer, respectively. In male induviduals over 30 years, the increase of melatonin level in winter was not registered, and in those over 40, the stable secretion of FTS and cortisol and decrease of alpha-MSH acrophase at spring time were observed. In healthy women under 40, melatonin level was heightened in follicular and luteal phase of cycle and that of FTS — in luteal phase. Stability of melatonin secretion and reduction of FTS content in luteal phase of cycle were typical for women over 40. The age-related disorders of indices were more pronounced upon tumor development. In men under 40 years suffering from melanoma and thymoma, circannual changes of pineal gland, thymus and hypophysial-adrenal system function were typical for healthy subjects after 40 years. In women with melanoma and thymoma under 40 years melatonin and FTS level during menstrual cycle were similar with those in healthy women over 40.
    [Show full text]
  • M.Sc. Organic Chemistry
    ST. JOSEPH’S COLLEGE (AUTONOMOUS) BENGALURU-27 DEPARTMENT OF CHEMISTRY SYLLABUS FOR POSTGRADUATE COURSE IN ORGANIC CHEMISTRY 2019-21 Re-accredited with ‘A++’ GRADE and 3.79/4 CGPA by NAAC Recognised as “College of Excellence” by UGC The Postgraduate programme in chemistry is designed to give students a good foundation in Chemistry and develop in them problem solving and experimental skills so that they are well prepared for further studies in specialized areas of Chemistry or for employment in academic institutions and in industry. Mission statement: To promote among our learners the skills of thinking, experimentation and application of the knowledge gained. To promote concern for environment and to develop appreciation for green Chemistry. To prepare our students for life in the larger community. Benchmark Statements for the Course: To instil in students a sense of enthusiasm for chemistry, an appreciation of its application in different contexts, and to involve them in intellectually stimulating and satisfying experience of learning and studying. To provide students with a broad and balanced foundation of chemical knowledge and practical skills. Teaching-Learning: Although the lecture method is extensively used, the students are also encouraged to do self- study through other activities like assignments, seminars, quiz, viva-voce etc. Co-curricular Activities: The Chemical Society for postgraduate (P.G.) students provides them with a platform to interact with students of other institutions and also with eminent scientists from
    [Show full text]
  • Polyphenylene Dendrimers
    Polyphenylene Dendrimers - Design and Synthesis of Monodisperse Functional Nanoparticles Dissertation zur Erlangung des Grades "Doktor der Wissenschaften" am Fachbereich Chemie und Pharmazie der Johannes Gutenberg-Universität in Mainz vorgelegt von Stefan Bernhardt geb. in Hofheim a. Ts. Mainz 2005 Dekan: Herr Prof. Dr. P. Langguth 1. Berichterstatter: 2. Berichterstatter: Tag der mündlichen Prüfung: 26.06.2006 Die vorliegende Arbeit wurde in der Zeit von März 2002 bis März 2005 am Max-Planck- Institut für Polymerforschung in Mainz unter Anleitung von Herrn Prof. Dr. K. Müllen durchgeführt. Dedicated to my wife If we knew what we were doing it wouldn't be research. Einstein, Albert Index of Abbreviations: AFM atomic force microscopy Anal. analysis calcd. calculated TBAF tetrabutylammoniumfluoride-hexahydrate CD2Cl2 deuterated methylenechloride δ chemical shift / ppm d doublet d8THF deuterated tetrahydrofuran DEE diethylether DMF dimethylformamide DMSO dimethylsulfoxide eq. equivalent EtOH ethanol FD field desorption G1, G2, G3, first-, second-, and third-dendrimer generation GS ground state h hours J coupling constant / Hz LE locally-excited state m multiplett m / g weight in gram MALDI-TOF matrix-assisted laser desorption/ionization-time of flight MCH methylcyclohexane MeOH methanol MS mass spectrometry n refractive index NMR nuclear magnetic resonance PE petroleum ether, low boiling PMI perylene monoimide PPh3 triphenylphosphine ppm parts per million (chemical shift in NMR spectroscopy) RT room temperature s singulet SM single molecule T temperature / °K or °C t triplet TCSPC time-correlated single photon counting TEA triethylamine THF tetrahydrofuran TIPS tri-iso-propylsilyl TPA triphenylamine UV ultraviolett Фflu fluorescence quantum yield τflu decay time of fluorescence kfwd and krev forward and reverse electron transfer rate constants CS charge-separated state Table of contents 1 INTRODUCTION................................................................................................
    [Show full text]
  • Enantioselective, Convergent Synthesis of the Ineleganolide Core by a Tandem Annulation Cite This: Chem
    Chemical Science View Article Online EDGE ARTICLE View Journal | View Issue Enantioselective, convergent synthesis of the ineleganolide core by a tandem annulation Cite this: Chem. Sci.,2017,8,507 cascade† Robert A. Craig, II, Jennifer L. Roizen, Russell C. Smith, Amanda C. Jones, Scott C. Virgil and Brian M. Stoltz* An enantioselective and diastereoselective approach toward the synthesis of the polycyclic norditerpenoid ineleganolide is disclosed. A palladium-catalyzed enantioselective allylic alkylation is employed to stereoselectively construct the requisite chiral tertiary ether and facilitate the synthesis of a 1,3-cis- cyclopentenediol building block. Careful substrate design enabled the convergent assembly of the ineleganolide [6,7,5,5]-tetracyclic scaffold by a diastereoselective cyclopropanation–Cope rearrangement cascade under unusually mild conditions. Computational evaluation of ground state energies of late-stage synthetic intermediates was used to guide synthetic development and aid in the Creative Commons Attribution 3.0 Unported Licence. investigation of the conformational rigidity of these highly constrained and compact polycyclic structures. This work represents the first successful synthesis of the core structure of any member of the furanobutenolide-derived polycyclic norcembranoid diterpene family of natural products. Advanced Received 28th July 2016 synthetic manipulations generated a series of natural product-like compounds that were shown to Accepted 15th August 2016 possess selective secretory antagonism of either interleukin-5 or interleukin-17. This bioactivity stands in DOI: 10.1039/c6sc03347d contrast to the known antileukemic activity of ineleganolide and suggests the norcembranoid natural www.rsc.org/chemicalscience product core may serve as a useful scaffold for the development of diverse therapeutics. This article is licensed under a Introduction this rigid polycyclic scaffold is decorated with a network of nine stereogenic centers, eight of which are contiguous.
    [Show full text]
  • Synthesis and Biosynthesis of Polyketide Natural Products
    Syracuse University SURFACE Chemistry - Dissertations College of Arts and Sciences 12-2011 Synthesis and Biosynthesis of Polyketide Natural Products Atahualpa Pinto Syracuse University Follow this and additional works at: https://surface.syr.edu/che_etd Part of the Chemistry Commons Recommended Citation Pinto, Atahualpa, "Synthesis and Biosynthesis of Polyketide Natural Products" (2011). Chemistry - Dissertations. 181. https://surface.syr.edu/che_etd/181 This Dissertation is brought to you for free and open access by the College of Arts and Sciences at SURFACE. It has been accepted for inclusion in Chemistry - Dissertations by an authorized administrator of SURFACE. For more information, please contact [email protected]. Abstract Traditionally separate disciplines of a large and broad chemical spectrum, synthetic organic chemistry and biochemistry have found in the last two decades a fertile common ground in the area pertaining to the biosynthesis of natural products. Both disciplines remain indispensable in providing unique solutions on numerous questions populating the field. Our contributions to this interdisciplinary pursuit have been confined to the biosynthesis of polyketides, a therapeutically and structurally diverse class of natural products, where we employed both synthetic chemistry and biochemical techniques to validate complex metabolic processes. One such example pertained to the uncertainty surrounding the regiochemistry of dehydration and cyclization in the biosynthetic pathway of the marine polyketide spiculoic acid A. The molecule's key intramolecular cyclization was proposed to occur through a linear chain containing an abnormally dehydrated polyene system. We synthesized a putative advanced polyketide intermediate and tested its viability to undergo a mild chemical transformation to spiculoic acid A. In addition, we applied a synthetic and biochemical approach to elucidate the biosynthetic details of thioesterase-catalyzed macrocyclizations in polyketide natural products.
    [Show full text]
  • MINIREVIEWS Central Nervous System-Immune System Interactions: Psychoneuroendocrinology of Stress and Its Immune Consequences PAUL H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1994, p. 1-6 Vol. 38, No. 1 0066-4804/94/$04.OO+O Copyright X 1994, American Society for Microbiology MINIREVIEWS Central Nervous System-Immune System Interactions: Psychoneuroendocrinology of Stress and Its Immune Consequences PAUL H. BLACK* Department ofMicrobiology, Boston University School ofMedicine, Boston, Massachusetts 02118 The past 20 years has witnessed the emergence of the field receiving information from the periphery, integrating it with of psychoneuroimmunology (48). This field deals with the the internal environment, and adjusting certain functions influence of the central nervous system (CNS) on the im- such as sympathetic nervous system function and endocrine mune system, or more specifically, whether and how secretion (28). The hypothalamus influences the pituitary thoughts and emotions affect immune function. Studies have gland through a variety of polypeptide "releasing factors," concentrated, for the most part, on the effects of stress on for example, corticotropin-releasing factor (CRF), which the immune system. Stress is defined as a state of dishar- controls the release of corticotropin (ACTH) from the ante- mony or threatened homeostasis provoked by a psycholog- rior pituitary gland. Other hypothalamic releasing hormones ical, environmental, or physiologic stressor (12, 40). It has (RHs) include thyrotropin RH, growth hormone RH, and also become apparent from these studies that the immune luteinizing hormone RH; these control the release of thyro- system can influence the CNS, and thus, a circuit exists tropin, growth hormone, gonadotropin, and luteinizing hor- between these two systems. Regulatory molecules or cyto- mone from the anterior pituitary gland. In addition, hypo- kines elaborated from activated immune cells evoke a thalamic somatostatin and dopamine inhibit the release of CNS response which, in turn, affects the immune system growth hormone and prolactin, respectively, from the ante- (26).
    [Show full text]
  • From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application Aleksandra Pekošak, Ulrike Filp, Alex J
    Mol Imaging Biol (2018) DOI: 10.1007/s11307-018-1163-5 * The Author(s), 2018. This article is an open access publication REVIEW ARTICLE From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application Aleksandra Pekošak, Ulrike Filp, Alex J. Poot, Albert D. Windhorst Radionuclide Center, Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1085c, 1081 HV, Amsterdam, The Netherlands Abstract Radiolabeled amino acids, their derivatives and peptides have a broad scope of application and can be used as receptor ligands, as well as enzyme substrates for many different diseases as radiopharmaceutical tracers. Over the past few decades, the application of molecular imaging techniques such as positron emission tomography (PET) has gained considerable importance and significance in diagnosis in today’s advanced health care. Next to that, the availability of cyclotrons and state-of-the-art radiochemistry facilities has progressed the production of imaging agents enabling the preparation of many versatile PET radiotracers. Due to many favorable characteristics of radiolabeled amino acids and peptides, they can be used for tumor staging and monitoring the progress of therapy success, while aromatic amino acids can be employed as PET tracer to study neurological disorders. This review provides a comprehensive overview of radiosynthetic and enzymatic approaches towards carbon-11 amino acids, their analogues and peptides, with focus on stereoselective reactions, and reflects upon their clinical application. Key Words: Carbon-11, Amino acid, Peptide, Radiolabeling, PET imaging Introduction D-glucose ([18F]FDG) as well as a large variety of other PET tracers like receptor ligands or enzyme substrates.
    [Show full text]
  • Convergent Synthesis of Thioether Containing Peptides
    molecules Article Convergent Synthesis of Thioether Containing Peptides Spyridon Mourtas 1,2, Christina Katakalou 1, Dimitrios Gatos 1 and Kleomenis Barlos 1,3,* 1 Department of Chemistry, University of Patras, 26510 Rio Patras, Greece; [email protected] (S.M.); [email protected] (C.K.); [email protected] (D.G.) 2 Institute of Chemical Engineering Sciences of the Foundation for Research and Technology Hellas (FORTH/IEC-HT), 26504 Rio Patras, Greece 3 CBL-Patras, Patras Industrial Area, Block 1, 25018 Patras, Greece * Correspondence: [email protected]; Tel.: +30-2610-647600; Fax: +30-2610-647316 Academic Editor: Theodore Tselios Received: 23 December 2019; Accepted: 3 January 2020; Published: 5 January 2020 Abstract: Thioether containing peptides were obtained following three synthetic routes. In route A, halo acids esterified on 2-chlorotrityl(Cltr) resin were reacted with N-fluorenylmethoxycarbonyl (Fmoc) aminothiols. These were either cleaved from the resin to the corresponding (Fmoc-aminothiol) carboxylic acids, which were used as key building blocks in solid phase peptide synthesis (SPPS), or the N-Fmoc group was deprotected and peptide chains were elongated by standard SPPS. The obtained N-Fmoc protected thioether containing peptides were then condensed either in solution, or on solid support, with the appropriate amino components of peptides. In route B, the thioether containing peptides were obtained by the reaction of N-Fmoc aminothiols with bromoacetylated peptides, which were synthesized on Cltr-resin, followed by removal of the N-Fmoc group and subsequent peptide elongation by standard SPPS. In route C, the thioether containing peptides were obtained by the condensation of a haloacylated peptide synthesized on Cltr-resin and a thiol-peptide synthesized either on 4-methoxytrityl(Mmt) or trityl(Trt) resin.
    [Show full text]
  • CV-PSB-August 2020
    Curriculum Vitae Phil S. Baran Appointment: Scripps Research Professor, Department of Chemistry 10550 North Torrey Pines Road, BCC-436 La Jolla, California 92037 Telephone: (858) 784-7373 Facsimile: (858) 784-7575 Email: [email protected] Website: www.scripps.edu/chem/baran/ January, 2013 Darlene Shiley Professor of Chemistry April, 2009 Member, Skaggs Institute for Chemical Biology June, 2008 Professor of Chemistry July, 2006 Associate Professor of Chemistry (with Tenure) June, 2003 Assistant Professor of Chemistry Date/Place of Birth: 10 Aug 1977 / Denville, NJ, USA Citizenship: United States Education 2001 – 2003 Postdoctoral Associate Advisor: Professor E.J. Corey Harvard University, Cambridge, Massachusetts 1997 – 2001 Ph.D. Graduate Student in Chemistry Advisor: Professor K.C. Nicolaou The Scripps Research Institute, La Jolla, California 1995 – 1997 B.S. with Honors in Chemistry Advisor: Professor D.I. Schuster New York University, New York, New York 1991 – 1995 Simultaneous high school graduation from Mt. Dora High School and A.A. degree with honors, Lake Sumter Community College, Florida Awards • Inhoffen Medal, 2019 • Manchot Research Professorship, 2017 • Member, The National Academy of Sciences, 2017 • Emanuel Merck Lectureship, 2017 • Blavatnik National Laureate in Chemistry, 2016 • ACS Elias J. Corey Award, 2016 • Member, American Academy of Arts and Sciences, 2015 • College of Arts and Science Alumni Distinguished Service Award, New York University, 2015 • Reagent of the Year Award (EROS), 2015 • Mukaiyama Award, 2014 •
    [Show full text]